[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334617-105":59,"doc-detail-334617-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","human-tissue-resident-peritoneal-macrophages-reveal-resistance-towards-oxidative-cell-stress-induced-by-non-invasive-physical-plasma","Human tissue-resident peritoneal macrophages reveal resistance towards oxidative cell stress induced by non-invasive physical plasma","","Multimodal abdominal cancer therapy faces persistently high recurrence rates, while long-term survival advantages remain limited by post-operative complications. Immune dysregulation, especially activation of peritoneal macrophages, drives massive cytokine release and rapid macrophage phenotype shifts, often causing treatment-limiting side effects. Plasma-activated liquids (PAL) are explored as adjuvants to reduce cytotoxicity and preserve healthy tissue. Primary human peritoneal macrophages exposed to PAL showed marked resistance, with enhanced proliferation and activation of anti-oxidative pathways that countered oxidative-stress–induced cell death, supporting potential immunomodulatory effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/human-tissue-resident-peritoneal-macrophages-reveal-resistance-towards-oxidative-cell-stress-induced-by-non-invasive-physical-plasma/334617/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/human-tissue-resident-peritoneal-macrophages-reveal-resistance-towards-oxidative-cell-stress-induced-by-non-invasive-physical-plasma/334617.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in abdominal cancer treatment?","Question",{"text":112,"@type":113},"Recurrence rates remain high, and long-term survival benefits are uncertain because post-operative complications and uncontrolled immune activation, especially of peritoneal macrophages, can cause severe side effects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the therapeutic approach investigated?",{"text":117,"@type":113},"The study examines plasma-activated liquids (PAL) as adjuvants for peritoneal cancer, aiming to mitigate side effects, preserve healthy tissue, and reduce cytotoxicity to non-cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"How did human peritoneal macrophages respond to PAL exposure?",{"text":121,"@type":113},"Exposed primary human macrophages showed pronounced resistance to PAL-induced oxidative stress, characterized by increased proliferation and activation of anti-oxidative pathways that countered oxidative-stress–driven cell death.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334617,1791104949,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","TYPE Original Research PUBLISHED 05 March 2024  \nDOI 10.3389/fimmu.2024.1357340  \nOPEN ACCESS  \nEDITED BY Kai Fang,  \nCedars Sinai Medical Center, United States  \nREVIEWED BY  \nNagendra Verma,  \nCedars Sinai Medical Center, United States Kristian Wende,  \nLeibniz Institute for Plasma Research and Technology e.V. (INP), Germany  \n*CORRESPONDENCE Martin Weiss  \n [martin.weiss@med.uni-tuebingen.de](martin.weiss@med.uni-tuebingen.de)  \nRECEIVED 17 December 2023  \nACCEPTED 14 February 2024  \nPUBLISHED 05 March 2024  \nCITATION  \nSchultze-Rhonhof L, Marzi J, Carvajal Berrio DA, Holl M, Braun T,  \nSchäfer-Ruoff F, Andress J, Bachmann C, Templin M, Brucker SY, Schenke-Layland K and Weiss M (2024) Human tissue-resident peritoneal macrophages reveal resistance towards oxidative cell stress induced by non-invasive physical plasma.  \nFront. Immunol. 15:1357340 .  \ndoi: 10.3389/fimmu.2024.1357340  \nCOPYRIGHT  \n© 2024 Schultze-Rhonhof, Marzi, Carvajal Berrio, Holl, Braun, Schäfer-Ruoff, Andress, Bachmann, Templin, Brucker, Schenke-Layland and Weiss. This is an  \nopen-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nHuman tissue-resident peritoneal macrophages reveal resistance towards oxidative cell stress induced by non-invasive physical plasma  \nLaura Schultze-Rhonhof 1, Julia Marzi 2,3,  \nDaniel Alejandro Carvajal Berrio 2, Myriam Holl 1, Theresa Braun 3,4, Felix Schäfer-Ruoff 3, Jürgen Andress 1, Cornelia Bachmann 1, Markus Templin3, Sara Y. Brucker 1, Katja Schenke-Layland 2,3 and Martin Weiss 1,3*  \n1 Department of Women ’s Health Tübingen, University of Tübingen, Tübingen, Germany, 2 Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, University of Tübingen, Tübingen, Germany, 3 Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany, 4 University Development, Research and Transfer, University of Konstanz, Konstanz, Germany  \nIn the context of multimodal treatments for abdominal cancer, including procedures such as cytoreductive surgery and intraperitoneal chemotherapy, recurrence rates remain high, and long-term survival beneﬁts are uncertain due to post-operative complications. Notably, treatment-limiting side effects often arise from an uncontrolled activation of the immune system, particularly peritoneally localized macrophages, leading to massive cytokine secretion and phenotype changes. Exploring alternatives, an increasing number of studies investigated the potential of plasma-activated liquids (PAL) for adjuvant peritoneal cancer treatment, aiming to mitigate side effects, preserve healthy tissue, and reduce cytotoxicity towards non-cancer cells. To assess the nontoxicity of PAL, we isolated primary human macrophages from the peritoneum and subjected them to PAL exposure. Employing an extensive methodological spectrum, including ﬂow cytometry, Raman microspectroscopy, and DigiWest protein analysis, we observed a pronounced resistance of macrophages towards PAL. This resistance was characterized by an upregulation of proliferation and anti-oxidative pathways, countering PAL-derived oxidative stress-induced cell death. The observed cellular effects of PAL treatment on human tissue-resident peritoneal macrophages unveil a potential avenue for PAL-derived immunomodulatory effects within the human peritoneal cavity. Our ﬁndings contribute to understanding the intricate interplay between PAL and macrophages, shedding light on the promising prospects for PAL in theadjuvant treatment of peritoneal cancer.  \nKEYWORDS  \nnon-invasive physical plasma (NIPP), cold atmospher","cbCaidn7UbhVzKdl","https://ap.wps.com/l/cbCaidn7UbhVzKdl","pdf",3047814,13,"English","# Introduction\n## Plasma-activated liquids and oxidative stress\n## Tissue-resident macrophages and immunomodulation\n# Methods and Measurements\n## Flow cytometry\n## Raman microspectroscopy\n## DigiWest protein analysis\n# Results\n## Resistance of macrophages to PAL\n## Upregulation of proliferation and anti-oxidative pathways\n# Discussion\n## Immunomodulatory potential in the peritoneal cavity\n# Conclusion\n## Prospects of PAL in adjuvant peritoneal cancer therapy","[{\"question\":\"What problem does the study address in abdominal cancer treatment?\",\"answer\":\"Recurrence rates remain high, and long-term survival benefits are uncertain because post-operative complications and uncontrolled immune activation, especially of peritoneal macrophages, can cause severe side effects.\"},{\"question\":\"What is the therapeutic approach investigated?\",\"answer\":\"The study examines plasma-activated liquids (PAL) as adjuvants for peritoneal cancer, aiming to mitigate side effects, preserve healthy tissue, and reduce cytotoxicity to non-cancer cells.\"},{\"question\":\"How did human peritoneal macrophages respond to PAL exposure?\",\"answer\":\"Exposed primary human macrophages showed pronounced resistance to PAL-induced oxidative stress, characterized by increased proliferation and activation of anti-oxidative pathways that countered oxidative-stress–driven cell death.\"}]","Human tissue-resident peritoneal macrophages reveal resistance towards oxidative cell stress induced by non-invasive physical plasma | PDF",1790007494,33]